Your browser doesn't support javascript.
loading
Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma.
Ka-Yue Chow, Larry; Lai-Shun Chung, Dittman; Tao, Lihua; Chan, Kui Fat; Tung, Stewart Yuk; Cheong Ngan, Roger Kai; Ng, Wai Tong; Wing-Mui Lee, Anne; Yau, Chun Chung; Lai-Wan Kwong, Dora; Ho-Fun Lee, Victor; Lam, Ka-On; Liu, Jiayan; Chen, Honglin; Dai, Wei; Lung, Maria Li.
Afiliação
  • Ka-Yue Chow L; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China.
  • Lai-Shun Chung D; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China.
  • Tao L; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China.
  • Chan KF; Department of Clinical Pathology, Tuen Mun Hospital, Hong Kong (SAR), PR China.
  • Tung SY; Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong (SAR), PR China.
  • Cheong Ngan RK; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China; Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong (SAR), PR China.
  • Ng WT; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong (SAR), PR China; University of Hong Kong-Shenzhen Hospital, Shenzhen, PR China.
  • Wing-Mui Lee A; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China; Department of Clinical Oncology, Pamela Youde Nethersole Eastern Hospital, Hong Kong (SAR), PR China; University of Hong Kong-Shenzhen Hospital, Shenzhen, PR China.
  • Yau CC; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China; Department of Oncology, Princess Margaret Hospital, Hong Kong (SAR) PR China.
  • Lai-Wan Kwong D; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China; University of Hong Kong-Shenzhen Hospital, Shenzhen, PR China.
  • Ho-Fun Lee V; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China; University of Hong Kong-Shenzhen Hospital, Shenzhen, PR China.
  • Lam KO; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China.
  • Liu J; Department of Microbiology, University of Hong Kong, Hong Kong (SAR), PR China.
  • Chen H; Department of Microbiology, University of Hong Kong, Hong Kong (SAR), PR China.
  • Dai W; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China; University of Hong Kong-Shenzhen Hospital, Shenzhen, PR China. Electronic address: weidai2@hku.hk.
  • Lung ML; Department of Clinical Oncology, University of Hong Kong, Hong Kong (SAR), PR China. Electronic address: mlilung@hku.hk.
EBioMedicine ; 86: 104357, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36371985
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Infecções por Vírus Epstein-Barr Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Nasofaríngeas / Infecções por Vírus Epstein-Barr Idioma: En Ano de publicação: 2022 Tipo de documento: Article